A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

EU in discussions with Pfizer, BioNTech about possibly reducing the 500 million COVID-19 vaccine purchases it has committed to buying this year or extending the deadline in exchange for a higher price; there is currently a glut of excess vaccines globally

US Patent Issued to TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gGmbH, BioNTech on Jan. 24 for "RNA formulation for immunotherapy" (German Inventors)

INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "AGENTS ENCODING CLDN6 AND CD3 BINDING ELEMENTS FOR TREATING CLDN6-POSITIVE CANCERS"

INTERNATIONAL PATENT: BIONTECH SE, GENMAB A/S FILES APPLICATION FOR "MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN COMBINATION THERAPY FOR CANCER"

US Patent Issued to BioNTech on Jan. 10 for "Coronavirus vaccine" (German Inventors)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count